Farxiga (Dapagliflozin) Safety Profile Differences in East Asian Patients
Evidence-based review of how dapagliflozin safety, pharmacokinetics, and dosing considerations differ in East Asian populations, including Japanese, Chinese, and Korean clinical trial data.
Read clinical review